These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2410178)

  • 1. Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification.
    Preston KL; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1985 Aug; 38(2):219-27. PubMed ID: 2410178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-administration of clonidine and oxazepam by methadone detoxification patients.
    Preston KL; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984 Mar; 49():192-8. PubMed ID: 6434959
    [No Abstract]   [Full Text] [Related]  

  • 3. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
    Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
    Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction.
    Ghodse H; Myles J; Smith SE
    Br J Psychiatry; 1994 Sep; 165(3):370-4. PubMed ID: 7994508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone combined with clonidine versus clonidine alone in opiate detoxification.
    Wilson RS; DiGeorge WS
    J Subst Abuse Treat; 1993; 10(6):529-35. PubMed ID: 8308937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine in outpatient detoxification from methadone maintenance.
    Kleber HD; Riordan CE; Rounsaville B; Kosten T; Charney D; Gaspari J; Hogan I; O'Connor C
    Arch Gen Psychiatry; 1985 Apr; 42(4):391-4. PubMed ID: 3977557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
    Levin FR; Fischman MW; Connerney I; Foltin RW
    Am J Addict; 1997; 6(2):105-16. PubMed ID: 9134072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal.
    Rounsaville BJ; Kosten T; Kleber H
    J Nerv Ment Dis; 1985 Feb; 173(2):103-10. PubMed ID: 3881558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydromorphone polymer implant. A potential alternative to methadone maintenance.
    Rhodes DJ; Grossman SA
    J Subst Abuse Treat; 1997; 14(6):535-42. PubMed ID: 9437625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
    Martin TJ; Kim SA; Buechler NL; Porreca F; Eisenach JC
    Anesthesiology; 2007 Feb; 106(2):312-22. PubMed ID: 17264726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users.
    Levy-Cooperman N; Schoedel KA; Reiz JL; Thompson D; Chakaraborty B; Geoffroy P; Michalko KJ
    J Opioid Manag; 2016; 12(3):165-80. PubMed ID: 27435437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
    Washton AM; Resnick RB; Geyer G
    J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine use and abuse among methadone program applicants and patients.
    Beuger M; Tommasello A; Schwartz R; Clinton M
    J Subst Abuse Treat; 1998; 15(6):589-93. PubMed ID: 9845872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone.
    Rosen MI; Wallace EA; McMahon TJ; Pearsall HR; Woods SW; Price LH; Kosten TR
    Drug Alcohol Depend; 1994 Apr; 35(2):141-9. PubMed ID: 7519977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of guanabenz in methadone withdrawal.
    Levadi DI
    Am J Psychiatry; 1985 Sep; 142(9):1128-9. PubMed ID: 4025641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.